The CEO of AION Labs discusses new ways to deploy AI in drug development and why Israel is becoming a hub for AI development in the pharmaceutical industry.
Pharma, AI, and the Case of Israel: Q&A with Matti Gill
You Might Also Like
Leave a Comment
Sign in to your account